Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,449,574
+$1,985,954 QoQ
Shares Held
711,811
-10.0% QoQ
Ownership
1.60%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $68,618,538 across 5 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
|
10,570,300 | $28,962,622 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,425,200 | $13,567,904 | |
| 3 | BIOA |
BioAge Labs, Inc.
This page
|
711,811 | $12,449,574 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
180,599 | $8,695,841 | |
| 5 | ADCT |
ADC Therapeutics SA
|
1,318,026 | $4,942,597 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,449,574 | 711,811 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,463,620 | 790,901 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,650,497 | 790,901 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,807,690 | 921,959 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,466,565 | 921,959 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,338,142 | 921,959 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,608,176 | 1,423,470 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||